🇺🇸 FDA
Patent

US 6190695

Pharmaceutical composition containing osteogenesis-promoting substance

expired A61KA61K31/40A61K31/445

Quick answer

US patent 6190695 (Pharmaceutical composition containing osteogenesis-promoting substance) held by Takeda Chemical Industries Ltd. expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/40, A61K31/445, A61K31/66, A61K31/683